About this journal
Aims and scope
The Journal of Biopharmaceutical Statistics , a rapid publication journal, discusses quality applications of statistics in biopharmaceutical research and development. Now publishing six times per year, it includes expositions of statistical methodology with immediate applicability to biopharmaceutical research in the form of full-length and short manuscripts, review articles, selected/invited conference papers, short articles, and letters to the editor. Addressing timely and provocative topics important to the biostatistical profession, the journal covers:
- Drug, device, and biological research and development
- Drug screening and drug design
- Assessment of pharmacological activity
- Pharmaceutical formulation and scale-up
- Preclinical safety assessment
- Bioavailability, bioequivalence, and pharmacokinetics
- Phase, I, II, and III clinical development including complex innovative designs
- Premarket approval assessment of clinical safety
- Postmarketing surveillance
- Big data and artificial intelligence and applications
All submitted manuscripts are subject to initial appraisal by the Editors. If found suitable for further consideration, papers are subject to peer review by two independent, anonymous expert referees, each delivering at least one report under the guidance of a team of expert Associate Editors. All peer-review is single anonymous and submissions can be made online via the Submission Portal.
Publishing Ethics Statement
The Journal adheres to the highest standards of publishing ethics, with rigorous processes in place to ensure this is achieved. Taylor & Francis is a member of the Committee of Publication Ethics (COPE) and utilizes Similarity Check for all Journals.
More information on our ethical standards and policies can be found here:
http://authorservices.taylorandfrancis.com/ethics-for-authors/.
The Journal has an appeals and complaints policy which can be viewed here:
https://authorservices.taylorandfrancis.com/peer-review-appeals-and-complaints-from-authors/
Author BenefitsAuthor Services
My Authored Works
Publication office: Taylor & Francis, Inc., 530 Walnut Street, Suite 850, Philadelphia, PA 19106.
Journal metrics
Usage
- 109K annual downloads/views
Citation metrics
- 1.2 (2023) Impact Factor
- Q2 Impact Factor Best Quartile
- 1.3 (2023) 5 year IF
- 2.5 (2023) CiteScore (Scopus)
- Q2 CiteScore Best Quartile
- 0.947 (2023) SNIP
- 0.812 (2023) SJR
Speed/acceptance
- 58 days avg. from submission to first decision
- 74 days avg. from submission to first post-review decision
- 16 days avg. from acceptance to online publication
- 38% acceptance rate
Understanding and using journal metrics
Journal metrics can be a useful tool for readers, as well as for authors who are deciding where to submit their next manuscript for publication. However, any one metric only tells a part of the story of a journal’s quality and impact. Each metric has its limitations which means that it should never be considered in isolation, and metrics should be used to support and not replace qualitative review.
We strongly recommend that you always use a number of metrics, alongside other qualitative factors such as a journal’s aims & scope, its readership, and a review of past content published in the journal. In addition, a single article should always be assessed on its own merits and never based on the metrics of the journal it was published in.
For more details, please read the Author Services guide to understanding journal metrics.
Journal metrics in brief
Usage and acceptance rate data above are for the last full calendar year and are updated annually in February. Speed data is updated every six months, based on the prior six months. Citation metrics are updated annually mid-year. Please note that some journals do not display all of the following metrics (find out why).
- Usage: the total number of times articles in the journal were viewed by users of Taylor & Francis Online in the previous calendar year, rounded to the nearest thousand.
Citation Metrics
- Impact Factor*: the average number of citations received by articles published in the journal within a two-year window. Only journals in the Clarivate Science Citation Index Expanded (SCIE), Social Sciences Citation Index (SSCI), Arts and Humanities Citation Index (AHCI) and the Emerging Sources Citation Index (ESCI) have an Impact Factor.
- Impact Factor Best Quartile*: the journal’s highest subject category ranking in the Journal Citation Reports. Q1 = 25% of journals with the highest Impact Factors.
- 5 Year Impact Factor*: the average number of citations received by articles in the journal within a five-year window.
- CiteScore (Scopus)†: the average number of citations received by articles in the journal over a four-year period.
- CiteScore Best Quartile†: the journal’s highest CiteScore ranking in a Scopus subject category. Q1 = 25% of journals with the highest CiteScores.
- SNIP (Source Normalized Impact per Paper): the number of citations per paper in the journal, divided by citation potential in the field.
- SJR (Scimago Journal Rank): Average number of (weighted) citations in one year, divided by the number of articles published in the journal in the previous three years.
Speed/acceptance
- From submission to first decision: the average (median) number of days for a manuscript submitted to the journal to receive a first decision. Based on manuscripts receiving a first decision in the last six months.
- From submission to first post-review decision: the average (median) number of days for a manuscript submitted to the journal to receive a first decision if it is sent out for peer review. Based on manuscripts receiving a post-review first decision in the last six months.
- From acceptance to online publication: the average (median) number of days from acceptance of a manuscript to online publication of the Version of Record. Based on articles published in the last six months.
- Acceptance rate: articles accepted for publication by the journal in the previous calendar year as percentage of all papers receiving a final decision.
For more details on the data above, please read the Author Services guide to understanding journal metrics.
*Copyright: Journal Citation Reports®, Clarivate Analytics
†Copyright: CiteScore™, Scopus
Editorial board
Editor-in-Chief:
Wen Zhou
Associate Professor, Colorado State University
Fort Collins, CO 80523 USA
Email: [email protected]
Co-Editor:
Margaret Gamalo-Siebers, PhD
Statistics Therapeutic Area Head – Inflammation and Immunology
GPD-Inflammation and Immunology, Pfizer
500 Arcola Road
Collegeville, PA 19426 USA
email: [email protected]
Managing Editors:
Victoria Chang
Director, Global Statistics and Data Science
BeiGene, Ltd.
1840 Gateway Drive, 3rd Floor
San Mateo, CA 94404
Tel: 669-246-8342
Email: [email protected]
Xiaofei Bai
Associate Director, Biostatistics
Servier Pharmaceuticals
200 Pier 4 Boulevard
Boston, MA 02210
Email: [email protected]
Honorary Advisory/Editorial Board Members:
Stan Altan - Senior Director, Johnson & Johnson, Raritan, NJ
A. Lawrence Gould (Editor 2000-2002) - Senior Director, Scientific Staff, Merck & Co., Inc., Blue Bell, PA
Gregory Campbell - Director, Biostatistics, FDA/CDRH, Rockville, MD
Kevin J. Carroll - Statistical Consultant, KJC Statistics, Cheadle, UK
Vernon Chinchilli - Distinguished Professor, Pennsylvania State University, Hershey, PA
Lutz Edler - Former Head of Division, Biostatistics,German Cancer Research Center, Heidelberg, Germany
Dean Follmann - Chief of Biostatistics Research Branch, NIAID, National Institutes of Health, Bethesda, MD
Paul Gallo - Senior Biometrical Fellow, Novartis Pharmaceuticals, East Hanover, NJ
Samiran Ghosh - Associate Professor, Wayne State University, Detroit, MI
Lan Huang - FDA, Silver Spring, MD, USA
Farid Kianifard - Director, Biostatistics, Novartis Pharmaceuticals, East Hanover, NJ
Gary Koch - Professor, University of North Carolina, Chapel Hill, NC
Jen-Pei Liu - Professor, National Taiwan University, Taipei, Taiwan
Dirk F. Moore - Associate Professor, Rutgers University, New Brunswick, NJ
Annpey Pong - Principal Scientist, Merck Research Institute, Morris, NJ
Steve Snapinn- Seattle-Quilcene Biostatistics LCC, Seattle, WA, USA
Roy Tamura - Associate Professor, University of South Florida, Tampa, FL, USA
Siu-Keung Tse - Associate Professor, City University of Hong Kong, Kowloon, Hong Kong
Yi Tsong - Deputy Division Director, FDA/CDER, Rockville, MD, USA
David Wright - Head of Statistical Innovation, AstraZeneca, Cambridge, UK
Daniel Zelterman - Co-Director, Yale Cancer Center, New Haven, CT, USA
Book Review Editor:
Wenjin. Wang - Senior Director, Pfizer Inc, Collegeville, PA
Associate Editors:
Yuki Ando - Senior Scientist, Pharmaceuticals and Medical Devices Agency, Tokyo, Japan
Carl-Fredrik Burman - Head of Quantitative Solutions, AstraZeneca, Mölndal, Sweden
Jie Chen - Head of Biometrics, Overland Pharmaceuticals, Warrington, PA, USA
Yeh-Fong Chen – Supervisory Mathematical Statistician, FDA/CDER*, Silver Spring, MD, USA
Alan Y. Chiang –Head of Biometrics, Lyell Immunopharma, Seattle, Washington, USA
Yi-Lin Chiu - Director and Department Head of Biometrics, AbbVie, North Chicago, IL, USA
Sumit Chopra - Associate Professor, New York University, New York, NY, USA
Tudor Cristea-Platon - Researcher, Apple Inc., Cambridge, MA, USA
Gaohong Dong -Director of Biostatistics, BeiGene Ltd., Ridgefield Park, NJ, USA
Vladimir Dragalin - Vice President and Scientific Fellow, Janssen Pharmaceutical Companies of Johnson & Johnson, Spring House, PA, USA
Haoda Fu - Associate Vice President, Eli Lilly and Company, Indianapolis, IN, USA
Pranab Ghosh-Director Biostatistics, Pfizer Inc, Acton, MA, USA
Samiran Ghosh - Associate Professor, Wayne State University, Detroit, MI, USA
Jiangtao Gou -Associate Professor, Villanova University, Villanova, PA, USA
Tony Xiang Guo - SVP, Global Statistics & Data Science, BeiGene, Ltd., Beijing, China
Chin-Fu Hsiao - Deputy Director/Investigator, National Health Research Institutes, Zhunan, Taiwan
Lihong Huang - Associate Professor, Fudan University, Shanghai, China
Jason C. Hsu - Professor Emeritus, Ohio State University, Columbus, OH, USA
Bo Jin - Vice President, Head of Data Science, Sumitomo Pharma Oncology, Inc, Marlborough, MA, USA
Man Jin - Director and Research Fellow, Statistics, AbbVie, North Chicago, IL, USA
Seung-Ho Kang - Professor, Yonsei University, Seoul, Korea
Meinhard Kieser - Director of the Institute of Medical Biometry and Informatics, University of Heidelberg, Heidelberg, Germany
John E. Kolassa - Distinguished Professor, Rutgers University, Piscataway, NJ, USA
Mengxing Li - Senior Data Scientist, Insightin, Baltimore, MD, USA
Xiaoyun Nicole Li - Executive Director, BeiGene Ltd., San Mateo, CA, USA
Jianchang Lin – Senior Director, Statistics, Takeda, Cambridge, MA, USA
Junjing Lin – Senior Director, Biostatistics, Takeda, Cambridge, MA, USA
Nelson T. Lu - Assistant Director, Biostatistics, FDA/CDRH*, Silver Spring, MD, USA
Tao Lu - Assistant Professor, SUNY Albany, Rensselaer, NY, USA
Arnab. K. Maity - Senior Manager, Pfizer, San Diego, CA, USA
Gu Mi - Director of Biostatistics, Sanofi, Cambridge, MA, USA
Satoshu Morita - Professor and Chairman, Kyoto University Graduate School of Medicine, Kyoto, Japan
David Paulucci - Director of Data Science, Bristol Myers Squibb, Lawrenceville, NJ, USA
Matthew A. Psioda -Head of Statistical Innovation for Oncology and Vaccines, GSK, Philadelphia, PA, USA
Nusrat Rabbee -Chief of Biostatistics and Clinical Epidemiology, NIH Clinical Center, San Francisco, CA, USA
Patrick M. Schnell - Assistant Professor, Ohio State University College of Public Health, Columbus, OH, USA
Yodit Seifu - Director, Bristol-Myers Squibb, Berkeley Heights, New Jersey, USA
Meiyu Shen - Lead Mathematical Statistician, FDA/CDER*, Silver Spring, MD, USA
Jyh-Ming Shoung - Director, Jansseen R&D, Johnson & Johnson, Raritan, NJ, USA
Say-Beng Tan - Executive Director, National Medical Research Council, Singapore
Sophie Hsiao-Hui Tsou - Associate Investigator, National Health Research Institutes, Zhunan, Taiwan
Yi Tsong - Division Director, FDA/CDER*, Silver Spring, MD, USA
Jung-Ying Tzeng - Professor, North Carolina State University, Raleigh, NC, USA
Duolao Wang -Professor, Liverpool School of Tropical Medicine, Liverpool, UK
Li Wang - Senior Director and Head of Statistical Innovation, AbbVie, North Chicago, IL, USA
Ming Wang - Associate Professor, Case Western Reserve University, Cleveland, OH, USA
Susan Q. Wang - Senior/Principal Clinical Data Scientist, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, USA
Xin Wang - Senior Director, Bristol Myers Squibb, Berkeley Heights, NJ, USA
Tu Xu - Director of Biostatistics, Novo Nordisk, Lexington, MA, USA
Hou-Cheng Yang - Edwards Lifesciences, Irvine, CA, USA
Miao Yang -Statistician, Seagen Inc, Bothell, WA, USA
Bingbing Yu -Associate Director, Oncology Biometrics, AstraZeneca, Gaithersburg, MD, USA
Godwin Yung - Principal Statistical Methodologist, Genentech Inc, South San Francisco, CA, USA
Tianyu Zhan - Associate Director, AbbVie, North Chicago, IL, USA
Jing Zhang - VP, Head of Biometrics, Adela, Inc., CA, USA
Lanju Zhang - Senior Director, Vertex Pharmaceuticals, Newton, MA, USA
Communications Editors:
Yodit Seifu - Merck & Co., Inc., Kenilworth, NJ
Junjing Lin - Takeda, Cambridge, MA
Emerging Insights and Commentaries Editor:
Qian Helen Li -Department of Biostatistics, StatsVita, Bethesda, MD, USA
Past Editors:
Karl E. Peace (Founding Editor, 1990-1999) - Georgia Cancer Coalition Distinguished Cancer Scholar, Senior Research Scientist, and Professor of Biostatistics,Georgia Southern University, Statesboro, GA, USA
A. Lawrence Gould (2000-2002) - Senior Director, Scientific Staff, Merck & Co., Inc., Blue Bell, PA, USA
Shein-Chung Chow (2003-2019) - Professor, Duke University School of Medicine, Durham, NC, USA
Abstracting and indexing
The Journal of Biopharmaceutical Statistics is abstracted/indexed in:
- Adis International Ltd.
Reactions Weekly (Online)
- American Statistical Association
Current Index to Statistics (Online)
- EBSCOhost (various)
- Elsevier BV
EMBASE
Scopus
- E-psyche
- Genamics JournalSeek
- National Library of Medicine
PubMed
- OCLC
ArticleFirst
Electronic Collections Online
- ProQuest (various)
- Springer
Zentralblatt MATH (Online)
- Statistical Theory and Method Abstracts (CD-ROM)
- Clarivate Analytics
Science Citation Index Expanded
Web of Science
- U.S. National Library of Medicine
MEDLINE
Open access
Journal of Biopharmaceutical Statistics is a hybrid open access journal that is part of our Open Select publishing program, giving you the option to publish open access. Publishing open access means that your article will be free to access online immediately on publication, increasing the visibility, readership, and impact of your research.
Why choose open access?
- Increase the discoverability and readership of your article
- Make an impact and reach new readers, not just those with easy access to a research library
- Freely share your work with anyone, anywhere
- Comply with funding mandates and meet the requirements of your institution, employer or funder
- Rigorous peer review for every open access article
Article Publishing Charges (APC)
If you choose to publish open access in this journal you may be asked to pay an Article Publishing Charge (APC). You may be able to publish your article at no cost to yourself or with a reduced APC if your institution or research funder has an open access agreement or membership with Taylor & Francis.
Use our APC finder to calculate your article publishing charge
6 issues per year
Advertising information
Would you like to advertise in Journal of Biopharmaceutical Statistics?
Reach an engaged target audience and position your brand alongside authoritative peer-reviewed research by advertising in Journal of Biopharmaceutical Statistics.
Taylor & Francis make every effort to ensure the accuracy of all the information (the "Content") contained in our publications. However, Taylor & Francis, our agents (including the editor, any member of the editorial team or editorial board, and any guest editors), and our licensors, make no representations or warranties whatsoever as to the accuracy, completeness, or suitability for any purpose of the Content. Any opinions and views expressed in this publication are the opinions and views of the authors, and are not the views of or endorsed by Taylor & Francis. The accuracy of the Content should not be relied upon and should be independently verified with primary sources of information. Taylor & Francis shall not be liable for any losses, actions, claims, proceedings, demands, costs, expenses, damages, and other liabilities whatsoever or howsoever caused arising directly or indirectly in connection with, in relation to, or arising out of the use of the Content. Terms & Conditions of access and use can be found at http://www.tandfonline.com/page/terms-and-conditions .
Ready to submit?
Start a new submission or continue a submission in progress
Go to submission site (link opens in a new window) Instructions for authors